Fresh Recalls

Cinacalcet Hydrochloride Tablets: recall status

⚠ Recalls found. Cinacalcet Hydrochloride Tablets is named in 3 official recalls in our current data:

Brand
Cipla USA

Recalls naming this model

FDA Class II · Drug · July 8, 2026

Cinacalcet Hydrochloride Tablets recall — Cipla USA, Inc.

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Company / brand: Cipla USA

Affected product: Cinacalcet Hydrochloride Tablets

Official ID D-0661-2026 · Official record ↗

FDA Class II · Drug · July 8, 2026

Cinacalcet Hydrochloride Tablets recall — Cipla USA, Inc.

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Company / brand: Cipla USA

Affected product: Cinacalcet Hydrochloride Tablets

Official ID D-0675-2026 · Official record ↗

FDA Class II · Drug · July 8, 2026

Cinacalcet Hydrochloride Tablets recall — Cipla USA, Inc.

cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Company / brand: Cipla USA

Affected product: Cinacalcet Hydrochloride Tablets

Official ID D-0676-2026 · Official record ↗

See all Cipla USA recalls →

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from connected official public-domain government data. Sources last checked September 7, 2026 at 6:00 AM UTC.